You are here: Home / Programme

Scientific Programme

4th Workshop on Emerging Issues in Oncogenic Virus Research
15–19 June 2016


Arrival of participants
Check in at Hotel dei Bizantini and Registration
20:00–24:00
Opening Dinner
At a local restaurant in Manduria (transport by bus)
08:00–09:00
Registration and Welcome Address
Session 1
09:00–13:20
Epidemiology
09:00–09:20
[O1]
Further studies on a model for predicting individual clinical outcome in patients with HPV-positive tonsillar and base of tongue cancer
Tina DALIANIS (Sweden)
09:20–09:35
[O2]
HPV16 integration in oropharyngeal cancer
Dana HOLZINGER (Germany)
09:35–09:50
[O3]
Human papillomavirus DNA is prevalent in fine-needle aspirates from patients with oropharyngeal cancer
Cecilia NORDFORS (Sweden)
09:50–10:10
[O4]
The potential of antibodies against HPV early proteins in detecting HPV-driven head and neck (pre-)cancer
Michael PAWLITA (Germany)
10:10–10:25
[O5]
The role of mucosal high-risk human papillomavirus types in oropharyngeal cancers in Romania
Ramona Gabriela URSU (Romania)
10:25–10:45
[O6]
Oncogenic infections in a rural Ugandan population
Robert NEWTON (Uganda)
10:45–11:00
[O7]
The impact of EPHA2 polymorphisms on KSHV infectivity and/or KS prevalence among HIV/AIDS patients in South Africa
Melissa BLUMENTHAL (South Africa)
11:00–11:30
Coffee break
11:30–11:45
[O8]
Natural history of anal human papillomavirus infection in HIV-uninfected men who have sex with men
Maria Gabriella DONÀ (Italy)
11:45–12:00
[O9]
Risk of virus-related non-AIDS-defining cancers in people with AIDS in São Paulo, Brazil
Luana FIENGO TANAKA (Brazil)
12:00–12:15
[O10]
Epidemiology of KSHV in the Ugandan general population during the HIV epidemic (1991–2008)
Denise WHITBY (USA)
12:15–12:30
[O11]
Shedding of KSHV and EBV in saliva of Ugandan children and their mothers
Nazzarena LABO (USA)
12:30–12:50
[O12]
Baseline cutaneous viral infections and ultraviolet radiation exposure in a cohort of skin cancer screening patients
Dana ROLLISON (USA)
12:50–13:05
[O13]
Beta-papillomavirus diversity at anogenital and oral anatomic sites of men: the HIM Study
Laura SICHERO (Brazil)
13:05–13:20
[O14]
Prevalence of cutaneous human papillomavirus infection in genital, oral, and anal samples
Shalaka HAMPRAS (USA)
13:20–15:00
Lunch
Session 2
15:00–18:25
Immunology
15:00–15:20
[O15]
Cancer as a disease of the symbiont/metaorganism
Giorgio TRINCHIERI (USA)
15:20–15:40
[O16]
A single dose of HPV vaccine improves B cell memory in previously infected subjects
Denise GALLOWAY (USA)
15:40–16:00
[O17]
cGMP production of a broad-spectrum chimeric RG1 virus–like particle (VLP) vaccine for prevention of HPV-induced mucosal and cutaneous neoplasia
Reinhard KIRNBAUER (Austria)
16:00–16:20
[O18]
Thermostable broadly protective HPV vaccine: final steps of pre-clinical development?
Martin MÜLLER (Germany)
16:20–16:40
[O19]
MUS Musculus papillomavirus 1 (MUSPV1/MMUPV1) infection of SKH1 mice as a model for immunotherapy
Richard B.S. RODEN (USA)
16:40–16:55
[O20]
VLP vaccination can prevent papillomavirus-induced disease in the horse
Edmund HAINISCH (Austria)
16:55–17:20
Coffee break
17:20–17:40
[O21]
BKPyV antibody level is associated with protection against development of progressive multifocal leukoencephalopathy
Raphael VISCIDI (USA)
17:40–17:55
[O22]
HPV16 E5 and its possible clinical use
Aldo VENUTI (Italy)
17:55–18:10
[O23]
HPV18 impairs both type I and III interferon induction by DNA ligand in keratinocytes
Silvia ALBERTINI (Italy)
18:10–18:25
[O24]
Involvement of ß-arrestins in CCR5 modulation pathway mediated by natural human antibodies
Assunta VENUTI (Italy)
18:25–20:00
Poster session with drinks
20:30
Dinner
Session 3
08:30–13:00
Virus–host interaction I
08:30–08:50
[O25]
HPV16 pseudovirus infection is inhibited by interferon-gamma treatment
Patricia DAY (USA)
08:50–09:10
[O26]
Racial differences in infectivity between European and non-European HPV16 variants
Craig MEYERS (USA)
09:10–09:25
[O27]
Spanning and penetration of the limiting membrane by the L2 capsid protein
Samuel CAMPOS (USA)
09:25–09:40
[O28]
The VPS4-ESCRT component is required for papillomavirus infectious entry
Justyna BRONIARCZYK (Italy)
09:40–10:00
[O29]
Replication strategies of papillomaviruses
Alison McBRIDE (USA)
10:00–10:20
[O30]
CTCF regulates differentiation-dependent human papillomavirus (HPV) gene expression
Joanna PARISH (UK)
10:20–10:40
[O31]
The interaction of papillomavirus (PV) E6 oncoproteins with LxxLL motifs: structure, function, and common and distinct features across PV species
Gilles TRAVÉ (France)
10:40–11:05
Coffee break
11:05–11:25
[O32]
Hacking of TIP60.com by human papillomavirus: how and why?
Sudhakar JHA (Singapore)
11:25–11:45
[O33]
Evidence of human papillomavirus and polyomavirus infection in tumours from a single-centre cohort of kidney transplant recipients
Marisa GARIGLIO (Italy)
11:45–12:05
[O34]
Deregulation of skin homeostasis by beta-HPV in vitro and in vivo: novel mechanisms
Sigrum SMOLA (Germany)
12:05–12:25
[O35]
BK and JC polyomaviruses make facultative use of heparin-like glycans for infectious entry
Christopher B. BUCK (USA)
12:25–12:40
[O36]
Towards an atomic resolution structure of the Merkel cell polyomavirus capsid and its glycosaminoglycan ligands
Bärbel BLAUM (Germany)
12:40–13:00
[O37]
Receptor engagement and immune evasion strategies of polyomaviruses
Thilo STEHLE (Germany)
13:00–15:30
Lunch
Session 4
15:30–19:30
Cellular transformation I
15:30–15:50
[O38]
Remodelling of ubiquitin and UbL signalling in Epstein–Barr virus–infected cells
Maria G. MASUCCI (Sweden)
15:50–16:10
[O39]
Novel aspects of Kaposi sarcoma herpesvirus (KSHV) LANA structure and function
Thomas SCHULZ (Germany)
16:10–16:30
[O40]
Interaction of the Merkel cell polyomavirus LT antigen with host cell chromatin
Nicole FISCHER (Germany)
16:30–16:50
[O41]
Exploitation of the SUMO pathway: novel insights into viral-mediated tumorigenesis
Susanna CHIOCCA (Italy)
16:50–17:10
[O42]
Identification of HPV E6 type–specific PDZ fingerprints that predict oncogenic potential
Lawrence BANKS (Italy)
17:10–17:25
[O43]
Identifying some unique oncogenic properties of Merkel cell polyomavirus
Noel WHITAKER (Australia)
17:25–17:40
[O44]
Antineoplastic efficacy of adenovirus Ad5/3-D24-GM-CSF and chemotherapy in mesothelioma
Lukasz KURYK (Finland)
17:40–18:00
Coffee break
18:00–18:20
[O45]
Do UV damage and Merkel polyomavirus target the same pathways in Merkel cell carcinoma?
James DeCAPRIO (USA)
18:20–18:40
[O46]
Role of ultraviolet radiation in papillomavirus-induced disease
Paul LAMBERT (USA)
18:40–19:00
[O47]
Of mice and men: biological activities and cellular targets of cutaneous papillomaviruses
Karl MÜNGER (USA)
19:00–19:15
[O48]
In vitro assays classify the HPV beta-3 species in low- , intermediate-, and high-risk types
Lucia MINONI (France)
19:15–19:30
[O49]
Beta HPV49 E6 and E7 synergize with 4-nitroquinoline 1-oxide in promoting cancer of the upper digestive tract in mice
Daniele VIARISO (Germany)
20:00–23:30
Dinner
At Masseria Potenti (transport by bus)
Session 5
08:30–13:00
Virus–host interaction II
08:30–08:50
[O50]
Receptor-dependent and -independent mechanisms of JC virus spread
Walter J. ATWOOD (USA)
08:50–09:10
[O51]
Gangliosides and the α4-integrin receptor mediate signalling events required for mouse polyomavirus infection
Robert L. GARCEA (USA)
09:10–09:30
[O52]
Entry of Merkel cell polyomavirus into A549 cells
Mario SCHELHAAS (Germany)
09:30–09:45
[O53]
The presumed polyomavirus viroporin VP4 of SV40 or BKPyV is not required for viral progeny release
Stian HENRIKSEN (Norway)
09:45–10:00
[O54]
Nucleosome positioning in SV40 minichromosomes and virions correlates with differential accessibility to regulatory regions
Barry MILAVETZ (USA)
10:00–10:20
[O55]
Large T antigen–based taxonomy: novel polyomaviruses prove the principle
Bernhard EHLERS (Germany)
10:20–10:40
[O56]
Understanding the BKPyV miRNA
Michael IMPERIALE (USA)
10:40–11:00
[O57]
Hepatitis C virus – coming to stay
Marco BINDER (Germany)
11:00–11:20
Coffee break
11:20–11:40
[O58]
Putting the “V” into SV40: molecular basis of virus-induced vacuolization
Daniel DiMAIO (USA)
11:40–12:00
[O59]
A shared class of small DNA viral non-coding RNAs antagonize the host antiviral response
Christopher SULLIVAN (USA)
12:55–12:15
[O60]
Human cytomegalovirus in vitro infection of glioblastoma-derived neurospheres increases self-renewal capacity and confers resistance to temozolomide
Rob KALEJTA (USA)
12:15–12:30
[O61]
KSHV latency-associated nuclear antigen (LANA) recruits components of the cellular MRN DNA damage response (DDR) repair complex to modulate an innate immunity signalling pathway and viral latency
Giuseppe MARIGGIO (Germany)
12:30–12:45
[O62]
A role for KSHV membrane proteins K1 and K15 in virus reactivation
Bizunesh ABERE ALAMIREW (Germany)
12:45–13:00
[O63]
Oncolytic adenoviruses encapsulated into the extracellular vesicles for cancer drug delivery
Mariangela GAROFALO (Finland)
13:00–16:00
Lunch
Session 6
16:00–18:05
Cellular transformation II
16:00–16:20
[O64]
Canonical NF-κB signalling in hepatocytes acts as a tumour-suppressor in HBV surface antigen-driven HCC by controlling the UPR
Mathias HEIKENWÄLDER (Germany)
16:20–16:40
[O65]
Understanding the Merkel cell polyomavirus and host interaction that contributes to virus-induced oncogenesis
Jianxin YOU (USA)
16:40–17:00
[O66]
Oncogenic human papillomaviruses deregulate polarity PDZ proteins using multiple mechanisms
Sally ROBERTS (UK)
17:00–17:15
[O67]
Gene expression pattern of human papillomavirus early oncogenes and p53-related genes in invasive cervical carcinoma and intraepithelial neoplasia
Clorinda ANNUNZIATA (Italy)
17:15–17:30
[O68]
Cell non-autonomous changes in stromal gene expression in a mouse model of HPV-associated cervical cancer
Megan SPURGEON (USA)
17:30–17:45
[O69]
Engineering of a novel organotypic model of the human cervical mucosa to study HPV-related cervical cancer
Vincenza DE GREGORIO (Italy)
17:45–18:05
[O70]
p53 plays a key role in regulation of cellular adhesion and migration in HPV38 E6/E7-expressing keratinocytes
Rosita ACCARDI (France)
18:05–19:30
Poster session with drinks
20:30
Social dinner
Departure – Shuttles to airport
Poster Sessions
Thursday 16 June 2016, 18:25–20:00
Saturday 18 June 2016, 18:05–19:30
P1
Understanding the shared link between stemness and carcinogenesis in MCV-positive cancer
Reety ARORA (India)
P2
The role of cellular senescence in virus replication
Maite BAZ-MARTÍNEZ (Spain)
P3
Alterations of microRNA expression in keratinocytes containing E6 and E7 of beta-3 HPV types
Sankhdeep DUTTA (France)
P4
Pseudovirus purification: implications for a novel mode of JCPyV infection
Gretchen GEE (USA)
P5
Prospective study of human polyomaviruses and risk of cutaneous squamous cell carcinoma in the United States
Anala GOSSAI (USA)
P6
Studies on the effects of irradiation on HLA class I expression in human papillomavirus positive and negative oropharyngeal squamous cell carcinoma cell lines
Linnea HAEGGBLOM (Sweden)
P7
Association of telomere length and cutaneous human papillomavirus infection with cutaneous squamous cell carcinoma
Shalaka HAMPRAS (USA)
P8
Identification of APMAP as part of the JCPyV attachment receptor complex
Sheila A. HALEY (USA)
P9
Prime–boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the human papillomavirus type 16 E6 and E7 mutated proteins fused to the coat protein of potato virus X
Elena ILLIANO (Italy)
P10
Pro-inflammatory cytokines and chemokines analysis in HPV-positive cancer cells
Marco IULIANO (Italy)
P11
The prevalence of infectious agents in oesophageal adenocarcinoma and Barrett′s oesophagus: a systematic review
Andrew KUNZMANN (UK)
P12
SNP –1486 T/C in the TLR9 promoter is associated with cervical cancer in Mexican women population
Cecilia MARTINEZ-CAMPOS (Mexico)
P13
Mathematical models of human papillomavirus clearance and persistence
Carmen Lia MURALL (France)
P14
Identification of cellular interaction partners of human papillomavirus minor capsid protein L2
Caroline ODENWALD (Germany)
P15
Human choroid plexus epithelial cells are susceptible to JCPyV infection
Bethany O′HARA (USA)
P16
E6 and E7 of human papillomavirus 38 alters the UV-induced cellular response by inhibiting the expression of toll-like receptor 9
Laura PACINI (France)
P17
Human papillomavirus 38 inhibits integrin alpha 1 expression via p53
Maria ROMERO (France)
P18
Vimentin modulates infectious internalisation of HPV16 pseudovirions
Georgia SCHÄFER (South Africa)
P19
Kinetics of human herpesvirus 8 in classic Kaposi sarcoma treated with electrochemotherapy
Noemy STARITA (Italy)
P20
PTPN14 is a novel interacting partner of the HPV E7 oncoprotein
Anita SZALMAS (Hungary)
P21
Analysis of phospho-regulation of the HPV E6 oncoproteins
Jayashree THATTE (Italy)
P22
Tonsil cancer and active HPV infection
Aldo VENUTI (Italy)